Published in Diabetologia on January 01, 1991
Action profiles of fast onset insulin analogues. Diabetologia (1990) 1.50
Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes (2006) 2.28
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest (1989) 2.25
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
The influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulin. Diabet Med (1995) 1.40
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg (2008) 1.35
The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res (1974) 1.28
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes (1997) 1.26
Does fall in tissue glucose precede fall in blood glucose? Diabetologia (1996) 1.26
Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia (2011) 1.25
A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet Med (1998) 1.21
Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm Metab Res Suppl (1988) 1.19
Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res (1976) 1.14
Hypergastrinemia induced by glucocorticoid and corticotropin treatment in man. Am J Dig Dis (1976) 1.09
Action of streptozotocin on insulin and glucagon responses of rat islets. Horm Metab Res (1970) 1.06
Effects of somatostatin on gastric secretion and gastrin release in man. Digestion (1975) 1.05
Gastrin concentration in plasma of the neonate at birth and after the first feeding. Pediatrics (1976) 1.04
Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab (2000) 1.03
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm Metab Res (1974) 1.00
Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs. Regul Pept (1980) 0.98
The UK Prospective Diabetes Study. Lancet (1998) 0.98
[Resynthesis of insulin from the preoxidized A chain and reduced B chain]. Justus Liebigs Ann Chem (1966) 0.97
Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring. Diabetes Care (1995) 0.97
Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol (2000) 0.96
Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest (1979) 0.95
Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can J Physiol Pharmacol (1989) 0.94
Paradoxical ACTH response to glucocorticoids in Cushing's disease. N Engl J Med (1977) 0.92
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab (1988) 0.92
Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes (1990) 0.91
Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes. Diabet Med (2012) 0.91
Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas. Horm Metab Res (1971) 0.91
Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med (2000) 0.90
Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology (1990) 0.90
[The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)]. MMW Munch Med Wochenschr (1976) 0.89
Amperometric biosensor for in vivo glucose sensing based on glucose oxidase immobilized in a redox hydrogel. Biosens Bioelectron (1994) 0.89
Stimulation of H-3-leucine incorporation into the proinsulin and insulin fraction of isolated pancreatic mouse islets in the presence of glucagon, theophylline and cyclic AMP. Diabetes (1973) 0.89
[Metabolic changes in zero-diet]. Internist (Berl) (1970) 0.89
Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab (1999) 0.89
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res (1993) 0.88
On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia (1992) 0.88
Insulin therapy in relation to circulating C-peptide levels. Diabetes (1978) 0.88
The effect of serotonin on in vitro insulin secretion and biosynthesis in mice. Diabetologia (1974) 0.87
Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr (1976) 0.87
Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology (1991) 0.86
[Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy]. Anaesthesist (2008) 0.86
Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism (1978) 0.85
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85
Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release. Horm Metab Res (1992) 0.85
Fetal hemoglobin in starvation ketosis of young women. Blood (1998) 0.85
Association between depression and subclinical carotid atherosclerosis in patients with Type 1 diabetes. Diabet Med (2008) 0.85
The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens Bioelectron (1993) 0.85
Glucose concentration in human subcutaneous adipose tissue: comparison between forearm and abdomen. Exp Clin Endocrinol Diabetes (1998) 0.85
On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985. Diabetologia (1987) 0.84
Symptom awareness is affected by the subjects' expectations during insulin-induced hypoglycemia. Diabetes Care (1997) 0.83
Does insulin play a role in the regulation of its own secretion? Horm Metab Res (1978) 0.83
Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care (1985) 0.83
Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp Brain Res (1980) 0.83
(Pro-) insulin biosynthesis and release of newly synthesized (pro-) insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas. Eur J Clin Invest (1975) 0.83
The influence of circulating thyroxine serum concentration on hepatic thyroxine deiodinating activity in rats. Exp Clin Endocrinol (1990) 0.83
[On the regulation of nonesterified fatty acids with special reference to prostaglandins]. Dtsch Med Wochenschr (1966) 0.83
Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Diabete Metab (1975) 0.83
Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia (1983) 0.82
Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism (1988) 0.82
Combination of microdialysis and glucosensor permits continuous (on line) SC glucose monitoring in a patient operated device. II. Evaluation in animals. Horm Metab Res (1992) 0.82
Isolation of IgG islet cell autoantibody-producing B lymphocytes from the peripheral blood of type 1 diabetic patients and an ICA-positive non-diabetic individual. Horm Metab Res (1989) 0.82
Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res (1976) 0.82
Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin. Horm Metab Res (1969) 0.82
Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db-db). Diabetologia (1973) 0.82
Histometric investigations on the testicular tissue of rats with alloxan diabetes and Chinese hamsters with spontaneous diabetes. Acta Endocrinol (Copenh) (1967) 0.81
Problems and artefacts in ACTH assay. Horm Metab Res (1972) 0.81
Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Diabetes Care (1981) 0.81
Long-term experiences with a computerized diabetes management and glucose monitoring system in insulin-dependent diabetic patients. Diabetes Res Clin Pract (1994) 0.81
Growth hormone radiologand assay unresponsive to human prolactin. J Clin Endocrinol Metab (1976) 0.81
Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation. J Clin Endocrinol Metab (1977) 0.81
Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man. Klin Wochenschr (1974) 0.81
Effect of beta-casomorphins and analogs on insulin release in dogs. Endocrinology (1983) 0.80
Left ventricular function at rest and during exercise in acute hypothyroidism. Br Heart J (1988) 0.80
Estimation of cholecystokinin-pancreozymin (CCK) in human plasma and tissue by a specific radioimmunoassay and the immunohistochemical identification of pancreozymin-producing cells in the duodenum of humans. Clin Chim Acta (1977) 0.80
Insulin secretion and biosynthesis in sucrose fed rats. Diabetologia (1976) 0.80
Effect of beta-casomorphins on somatostatin release in dogs. Endocrinology (1983) 0.80
Release of immunoreactive and radioactively prelabelled endogenous (pro)-insulin from isolated islets of rat pancreas in the presence of exogenous insulin. J Endocrinol (1977) 0.80
Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism (1984) 0.80
Inhibition of frusemide-induced hyperreninaemia by growth-hormone release-inhibiting hormone in man. Lancet (1976) 0.80
Continuous glucose monitoring reveals associations of glucose levels with QT interval length. Diabetes Technol Ther (2010) 0.80